Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Pegfilgrastim (Shandong Kexing Bioproducts), 升白针, 聚乙二醇化人粒细胞刺激因子(科兴生物制药) + [1] |
Target |
Action agonists |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemotherapy-Induced Febrile Neutropenia | Phase 3 | China | 31 Dec 2024 |
Phase 2 | 70 | PEG-rhG-CSF+rhG-CSF (AOB) | tgzqjvxppw(smbrdcrxjx) = aqtsnvqdwp lbnsavflec (xveqbzmcgk ) View more | Positive | 31 May 2023 | ||
rhG-CSF+PEG-rhG-CSF (BOA) | tgzqjvxppw(smbrdcrxjx) = ajmprtoxvo lbnsavflec (xveqbzmcgk ) View more |